Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Augmentation of learning in schizophrenia by d-serine and auditory remediation is related to auditory and frontally-generated biomarkers: A randomized, double-blind, placebo-controlled study.
Govani V, Shastry AM, Iosifescu DV, Govil P, Mayer MR, Sobeih T, Choo TH, Wall MM, Sehatpour P, Kantrowitz JT. Govani V, et al. Among authors: sobeih t. Schizophr Res. 2023 Oct;260:205-208. doi: 10.1016/j.schres.2023.08.027. Epub 2023 Sep 11. Schizophr Res. 2023. PMID: 37690312 Clinical Trial. No abstract available.
Augmentation of learning in schizophrenia by D-serine is related to auditory and frontally-generated biomarkers: A randomized, double-blind, placebo-controlled study.
Govani V, Shastry A, Iosifescu D, Govil P, Mayer M, Sobeih T, Choo T, Wall M, Sehatpour P, Kantrowitz J. Govani V, et al. Among authors: sobeih t. Res Sq [Preprint]. 2023 May 19:rs.3.rs-2943290. doi: 10.21203/rs.3.rs-2943290/v1. Res Sq. 2023. PMID: 37293030 Free PMC article. Updated. Preprint.
Dose-Dependent Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia: A Double-Blind, Placebo-Controlled, Randomized, Target Engagement Clinical Trial of the NMDA Glutamate Receptor Agonist d-serine.
Sehatpour P, Iosifescu DV, De Baun HM, Shope C, Mayer MR, Gangwisch J, Dias E, Sobeih T, Choo TH, Wall MM, Medalia A, Saperstein AM, Kegeles LS, Girgis RR, Carlson M, Kantrowitz JT. Sehatpour P, et al. Among authors: sobeih t. Biol Psychiatry. 2023 Jul 15;94(2):164-173. doi: 10.1016/j.biopsych.2023.01.015. Epub 2023 Jan 28. Biol Psychiatry. 2023. PMID: 36958998 Clinical Trial.
OnTrackNY's learning healthcare system.
Humensky JL, Bello I, Malinovsky I, Nossel I, Patel S, Jones G, Cabassa LJ, Radigan M, Sobeih T, Tobey C, Basaraba C, Scodes J, Smith T, Wall M, Labouliere C, Stanley B, Dixon LB. Humensky JL, et al. Among authors: sobeih t. J Clin Transl Sci. 2020 Apr 6;4(4):301-306. doi: 10.1017/cts.2020.35. J Clin Transl Sci. 2020. PMID: 33244410 Free PMC article.
Grant Report on d-Serine Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia †.
de la Garrigue N, Glasser J, Sehatpour P, Iosifescu DV, Dias E, Carlson M, Shope C, Sobeih T, Choo TH, Wall MM, Kegeles LS, Gangwisch J, Mayer M, Brazis S, De Baun HM, Wolfer S, Bermudez D, Arnold M, Rette D, Meftah AM, Conant M, Lieberman JA, Kantrowitz JT. de la Garrigue N, et al. Among authors: sobeih t. J Psychiatr Brain Sci. 2020;5(4):e200018. Epub 2020 Aug 6. J Psychiatr Brain Sci. 2020. PMID: 32856005 Free PMC article.
Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers.
Kantrowitz JT, Grinband J, Goff DC, Lahti AC, Marder SR, Kegeles LS, Girgis RR, Sobeih T, Wall MM, Choo TH, Green MF, Yang YS, Lee J, Horga G, Krystal JH, Potter WZ, Javitt DC, Lieberman JA. Kantrowitz JT, et al. Among authors: sobeih t. Neuropsychopharmacology. 2020 Oct;45(11):1842-1850. doi: 10.1038/s41386-020-0706-z. Epub 2020 May 13. Neuropsychopharmacology. 2020. PMID: 32403118 Free PMC article. Clinical Trial.
Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients.
Kantrowitz JT, Javitt DC, Freedman R, Sehatpour P, Kegeles LS, Carlson M, Sobeih T, Wall MM, Choo TH, Vail B, Grinband J, Lieberman JA. Kantrowitz JT, et al. Among authors: sobeih t. Neuropsychopharmacology. 2020 Jul;45(8):1339-1345. doi: 10.1038/s41386-020-0628-9. Epub 2020 Feb 3. Neuropsychopharmacology. 2020. PMID: 32015461 Free PMC article. Clinical Trial.
15 results